Trillium Therapeutics Inc. (TSX:TR) is an immuno -
oncology company dedicated to the discovery and development of novel and innovative cancer therapies.

NEWS SIGN UP

Email Address: *
First Name:


Powered By Q4 Web Systems 4.0.7.266